查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1610027

神經痛治療市場規模、佔有率、趨勢分析報告：按治療、按最終用途、按地區、細分市場預測，2025-2030 年

Neuralgia Treatment Market Size, Share & Trends Analysis Report By Treatment (Drug Based, Surgery), By End Use (Hospital & Clinics, Ambulatory Surgery Centers), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

神經痛治療市場的成長與趨勢

預計2030年全球神經痛治療市場規模將達34.3億美元，2025年至2030年複合年成長率預計為6.7%。老年人口的增加、三叉神經痛發生率的增加以及糖尿病盛行率的增加是推動市場的關鍵因素。神經痛是神經損傷或發炎引起的灼痛、刺痛。

慢性神經疼痛可由多種因素引起，包括感染疾病、糖尿病、老齡化、多發性硬化症或損害保護某些神經的髓鞘的類似疾病。壓迫三叉神經的腫瘤也會引起這種疾病。慢性三叉神經痛的盛行率隨著年齡的成長而增加。根據世界衛生組織發布的估計，老年人口數量預計將從2015年的9億增加到2050年的20億。老年人更容易患糖尿病、三叉神經痛等多種疾病。

根據美國神經肌肉的資料，三叉神經痛通常發生在 50 歲以上的人身上。另據報導，女性比男性更容易患三叉神經痛。根據國際疼痛研究協會（IASP）發表的一項名為《患者的三叉神經痛之旅》的研究顯示，一般人群中三叉神經痛的發生率為每10萬人中3.4至5.9人。也有報道稱，老年人中發病率較高。預計這些因素將在預測期內推動市場成長。立體定位放射線手術和微血管減壓手術術是治療這種疾病最常用的治療方法。

神經疼痛治療市場報告亮點

  • 手術細分市場將佔據市場主導地位，到 2024 年將佔 64.8% 的佔有率。對機器人放射線手術等精確和非侵入性治療方案的需求不斷成長是該領域的主要驅動力。
  • 預計在預測期內，基於藥物的細分市場將以 7.0% 的最快複合年成長率成長。
  • 2024 年，醫院和診所部門佔據最大的市場收益佔有率。醫院和診所採用先進的非侵入性技術將透過提供更精確和有針對性的治療來推動市場。
  • 預計門診手術中心部分在預測期內將以最快的複合年成長率成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 神經痛治療的變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營商環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章神經痛治療市場：依治療的商業分析

  • 2024年及2030年治療市場佔有率
  • 治療細分儀表板
  • 2018-2030 年市場規模、預測與趨勢分析（按處理方式）
  • 基於藥物的
  • 外科手術

第5章神經疼痛治療市場：最終用途的商業分析

  • 2024 年及 2030 年最終用途市場佔有率
  • 最終用途細分儀表板
  • 2018-2030 年按最終用途分類的市場規模、預測與趨勢分析
  • 醫院/診所
  • 門診手術中心
  • 其他

第6章神經痛治療市場：按國家分類的估計和趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與者概覽
  • 公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介/上市公司
    • GSK plc.
    • Pfizer Inc.
    • Novartis AG
    • Biogen
    • Zydus Group（Cadila Healthcare Limited）
    • H. Lundbeck A/S
Product Code: GVR-4-68039-022-8

Neuralgia Treatment Market Growth & Trends:

The global neuralgia treatment market size is expected to reach USD 3.43 billion in 2030 and is projected to grow at a CAGR of 6.7% from 2025 to 2030. The rising geriatric population, increasing incidence of trigeminal neuralgia, and the growing prevalence of diabetes are the key factors driving the market. Neuralgia is a burning, stabbing, and severe pain due to a damaged or irritated nerve.

The chronic pain in the nerves can occur due to various factors such as infection, diabetes, aging, multiple sclerosis, or any similar disorders that damage the myelin sheath protecting certain nerves. Tumor compressing the trigeminal nerve can also cause the disorder. The prevalence of chronic pain in the trigeminal nerve increases with the aging population. According to the estimates published by the WHO, the geriatric population is anticipated to rise from 900.0 million in 2015 to 2.0 billion in 2050. The geriatric population is prone to many diseases such as diabetes and trigeminal neuralgia.

As per the American Association of Neuromuscular and Electrodiagnostic Medicine, the disorder usually affects the population aged 50 years or older. It also reported that women are more prone to trigeminal neuralgia than men. As per the study, The Patient's Journey Through Trigeminal Neuralgia published by the International Association for The Study of Pain (IASP), the incidence rate of the disorder in the general population is 3.4 to 5.9 per 100,000 population. It also reported that the incidence rate is comparatively higher in the geriatric population. Such factors are expected to boost market growth over the forecast period. Stereotactic radiosurgery and microvascular decompression are the two most common procedures being adopted to treat the disorder.

Neuralgia Treatment Market Report Highlights:

  • The surgery segment dominated the market and accounted for a share of 64.8% in 2024. The growing demand for precise, non-invasive treatment options, such as robotic radiosurgery, is a key driver for the segment
  • The drug-based segment is expected to grow at the fastest CAGR of 7.0% over the forecast period
  • The hospital & clinics segment accounted for the largest market revenue share in 2024. Adopting advanced, non-invasive technologies in hospitals and clinics drives the market by providing more accurate and targeted treatments
  • The ambulatory surgery centers segment is expected to grow at the fastest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Neuralgia Treatment Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Neuralgia Treatment Market: Treatment Business Analysis

  • 4.1. Treatment Market Share, 2024 & 2030
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Drug Based
    • 4.4.1. Drug based market, 2018 - 2030 (USD Million)
    • 4.4.2. Anticonvulsant medicines
      • 4.4.2.1. Anticonvulsant medicines market, 2018 - 2030 (USD Million)
    • 4.4.3. Tricyclic antidepressants
      • 4.4.3.1. Tricyclic antidepressants market, 2018 - 2030 (USD Million)
  • 4.5. Surgery
    • 4.5.1. Surgery market, 2018 - 2030 (USD Million)
    • 4.5.2. Radiofrequency Thermal Lesioning
      • 4.5.2.1. Radiofrequency thermal lesioning market, 2018 - 2030 (USD Million)
    • 4.5.3. Stereotactic Radiosurgery
      • 4.5.3.1. Stereotactic radiosurgery market, 2018 - 2030 (USD Million)
    • 4.5.4. Microvascular Decompression
      • 4.5.4.1. Microvascular decompression market, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Neuralgia Treatment Market: End Use Business Analysis

  • 5.1. End Use Market Share, 2024 & 2030
  • 5.2. End Use Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospital & Clinics
    • 5.4.1. Hospital & clinics market, 2018 - 2030 (USD Million)
  • 5.5. Ambulatory Surgery Centers
    • 5.5.1. Ambulatory surgery centers market, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Neuralgia Treatment Market: Country Estimates & Trend Analysis by Product and Technology

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key country dynamic
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive insights
      • 6.4.2.4. U.S. neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key country dynamic
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive insights
      • 6.4.3.4. Canada neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key country dynamic
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive insights
      • 6.4.4.4. Mexico neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key country dynamic
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive insights
      • 6.5.2.4. UK neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key country dynamic
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive insights
      • 6.5.3.4. Germany neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key country dynamic
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive insights
      • 6.5.4.4. France neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key country dynamic
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive insights
      • 6.5.5.4. Italy neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key country dynamic
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive insights
      • 6.5.6.4. Spain neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Russia
      • 6.5.7.1. Key country dynamic
      • 6.5.7.2. Regulatory framework
      • 6.5.7.3. Competitive insights
      • 6.5.7.4. Russia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamic
      • 6.5.8.2. Regulatory framework
      • 6.5.8.3. Competitive insights
      • 6.5.8.4. Denmark neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key country dynamic
      • 6.5.9.2. Regulatory framework
      • 6.5.9.3. Competitive insights
      • 6.5.9.4. Sweden neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.10. Norway
      • 6.5.10.1. Key country dynamic
      • 6.5.10.2. Regulatory framework
      • 6.5.10.3. Competitive insights
      • 6.5.10.4. Norway neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamic
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive insights
      • 6.6.2.4. Japan neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key country dynamic
      • 6.6.3.2. Regulatory framework
      • 6.6.3.3. Competitive insights
      • 6.6.3.4. China neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key country dynamic
      • 6.6.4.2. Regulatory framework
      • 6.6.4.3. Competitive insights
      • 6.6.4.4. India neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key country dynamic
      • 6.6.5.2. Regulatory framework
      • 6.6.5.3. Competitive insights
      • 6.6.5.4. Australia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamic
      • 6.6.6.2. Regulatory framework
      • 6.6.6.3. Competitive insights
      • 6.6.6.4. Thailand neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. South Korea
      • 6.6.7.1. Key country dynamic
      • 6.6.7.2. Regulatory framework
      • 6.6.7.3. Competitive insights
      • 6.6.7.4. South Korea neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key country dynamic
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive insights
      • 6.7.2.4. Brazil neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key country dynamic
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive insights
      • 6.7.3.4. Argentina neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key country dynamic
      • 6.8.2.2. Regulatory framework
      • 6.8.2.3. Competitive insights
      • 6.8.2.4. South Africa neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key country dynamic
      • 6.8.3.2. Regulatory framework
      • 6.8.3.3. Competitive insights
      • 6.8.3.4. Saudi Arabia neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key country dynamic
      • 6.8.4.2. Regulatory framework
      • 6.8.4.3. Competitive insights
      • 6.8.4.4. UAE neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key country dynamic
      • 6.8.5.2. Regulatory framework
      • 6.8.5.3. Competitive insights
      • 6.8.5.4. Kuwait neuralgia treatment market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. GSK plc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Pfizer Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Novartis AG
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Biogen
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Zydus Group (Cadila Healthcare Limited)
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. H. Lundbeck A/S
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product benchmarking
      • 7.5.6.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global neuralgia treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global neuralgia treatment market, by product, 2018 - 2030 (USD Million)
  • Table 5. Global neuralgia treatment market, by application, 2018 - 2030 (USD Million)
  • Table 6. Global neuralgia treatment market, by portability, 2018 - 2030 (USD Million)
  • Table 7. Global neuralgia treatment market, by type, 2018 - 2030 (USD Million)
  • Table 8. Global neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 9. North America neuralgia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 10. North America neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 11. North America neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 12. U.S. neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13. U.S. Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 14. Canada neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 15. Canada neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Mexico neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17. Mexico neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 18. Europe neuralgia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 19. Europe neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 20. Europe neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 21. UK neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 22. UK Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Germany neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 24. Germany neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 25. France neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 26. France Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Italy neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 28. Italy neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Spain neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 30. Spain neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 31. Russia neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32. Russia neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Denmark neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 34. Denmark neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 35. Sweden neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36. Sweden neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Norway neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38. Norway Neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 39. Asia Pacific neuralgia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 40. Asia Pacific neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 41. Asia Pacific neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 42. Japan neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 43. Japan neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 44. China neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 45. China neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 46. India neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 47. India neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Australia neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 49. Australia neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 50. South Korea neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 51. South Korea neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Thailand neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 53. Thailand neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 54. Latin America neuralgia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 55. Latin America neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 56. Latin America neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 57. Brazil neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 58. Brazil neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 59. Argentina neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 60. Argentina neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 61. Middle East & Africa Neuralgia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 62. Middle East & Africa neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 63. Middle East & Africa neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 64. South Africa neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 65. South Africa neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Saudi Arabia neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 67. Saudi Arabia neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 68. UAE neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 69. UAE neuralgia treatment market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Kuwait neuralgia treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 71. Kuwait neuralgia treatment market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neuralgia Treatment segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Treatment and end use outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Neuralgia treatment dynamics
  • Fig. 12 Neuralgia treatment market: Porter's five forces analysis
  • Fig. 13 Neuralgia treatment market: PESTLE analysis
  • Fig. 14 Neuralgia treatment market: Treatment segment dashboard
  • Fig. 15 Neuralgia treatment market: Treatment market share analysis, 2024 & 2030
  • Fig. 16 Drug based market, 2018 - 2030 (USD Million)
  • Fig. 17 Surgery market, 2018 - 2030 (USD Million)
  • Fig. 18 Neuralgia treatment market: End Use segment dashboard
  • Fig. 19 Neuralgia treatment market: End Use market share analysis, 2024 & 2030
  • Fig. 20 Radiofrequency thermal lesioning market, 2018 - 2030 (USD Million)
  • Fig. 21 Stereotactic radiosurgery market, 2018 - 2030 (USD Million)
  • Fig. 22 Microvascular decompression market, 2018 - 2030 (USD Million)
  • Fig. 23 Others market, 2018 - 2030 (USD Million)
  • Fig. 24 Neuralgia treatment market revenue, by region
  • Fig. 25 Regional marketplace: Key takeaways
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 North America neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. country dynamics
  • Fig. 29 U.S. neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada country dynamics
  • Fig. 31 Canada neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico country dynamics
  • Fig. 33 Mexico neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 UK country dynamics
  • Fig. 36 UK neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany country dynamics
  • Fig. 38 Germany neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 France country dynamics
  • Fig. 40 France neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy country dynamics
  • Fig. 42 Italy neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain country dynamics
  • Fig. 44 Spain neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 45 Russia country dynamics
  • Fig. 46 Russia neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark country dynamics
  • Fig. 48 Denmark neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway country dynamics
  • Fig. 52 Norway neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand country dynamics
  • Fig. 63 Thailand neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea country dynamics
  • Fig. 65 South Korea neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 MEA neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait Key country dynamics
  • Fig. 79 Kuwait neuralgia treatment market, 2018 - 2030 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework